Valuation: China Isotope & Radiation Corporation

Market Cap 3.08B 3.62B 462M 419M 387M 349M 658M 43.56B 682M 4.65B 1.84B 23.27B 1.73B 1.7B 73.86B P/E 2024
8.03x
P/E 2025 17.7x
Enterprise Value 3.2B 3.76B 480M 435M 402M 363M 684M 45.23B 708M 4.83B 1.92B 24.16B 1.8B 1.76B 76.7B EV / Sales 2024
0.42x
EV / Sales 2025 0.82x
Free-Float
91.44%
Yield 2024
3.74%
Yield 2025 1.69%
Oct. 22 China Isotope & Radiation to Issue New Shares in Subsidiary; Shares Fall 4% MT
Oct. 21 China Isotope & Radiation Declares Interim Dividend MT
Oct. 21 China Isotope & Radiation Corporation Approves Appointment of Li Penghui as Executive Director, Effective 21 October 2026 CI
Oct. 21 China Isotope & Radiation Corporation Approves Interim Dividend for the Six Months Ended 30 June 2026, Payable Before 18 December 2026 CI
Oct. 11 CIRC Unit's H. Pylori Breath Test Kit Wins China Drug Registration Approval MT
Sep. 22 China Isotope & Radiation Unit's Lu-177 API Filing Clears US FDA Review MT
Aug. 28 China Isotope & Radiation Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 CI
Aug. 28 China Isotope & Radiation Corporation Proposes Interim Dividend for the Six Months Ended 30 June 2026, Payable on 18 December 2026 CI
Aug. 28 China Isotope & Radiation Corporation Announces Resignation of Zhang Junqi as an Executive Director, A Member of the Strategy Committee of the Board and A Member of the Science and Technology Innovation Committee of the Board, Effective August 28, 2026 CI
Aug. 28 China Isotope & Radiation Corporation Announces CEO Changes, Effective August 28, 2026 CI
Jul. 05 China Isotope to Form JV With Associate MT
Jul. 03 China Isotope & Radiation Corporation and CNNC Yuanke Enter into Shareholders? Agreement to Establish Joint Venture Company CNNC Fuyuan CI
Jun. 18 China Isotope & Radiation Corporation Approves Final Dividend for the Year Ended 31 December 2025, Payable on Before 17 August 2026 CI
1 day-4.79%
1 week-3.33%
Current month-3.49%
1 month-7.13%
3 months-33.78%
6 months-40.31%
Current year-43.91%
1 week 11.32
Extreme 11.32
11.95
1 month 11
Extreme 11
12.8
Current year 11
Extreme 11
24.28
1 year 11
Extreme 11
24.28
3 years 9.03
Extreme 9.03
25
5 years 9.03
Extreme 9.03
26.5
10 years 9.03
Extreme 9.03
35.4
Manager TitleAgeSince
Chief Executive Officer 54 2026-08-27
Corporate Secretary - 2024-08-29
Corporate Secretary - 2024-08-29
Director TitleAgeSince
Director/Board Member 57 2017-02-21
Director/Board Member 54 2019-06-27
Director/Board Member 54 2019-12-29
Change 5-day change 1-year change 3-year change Capi.($)
-4.79%-3.33%-51.54%-11.76% 462M
+1.18%-1.28%-16.90%+11.78% 188B
+1.85%+1.04%+7.29%+41.70% 126B
-0.88%-4.98%-14.52%+9.40% 118B
+1.36%-5.91%-42.82%+1.32% 92.48B
+2.96%+7.64%-0.80%+84.71% 68.51B
+1.08%+2.90%+12.95%-6.56% 59.39B
+0.89%+4.17%+2.07%+55.03% 55.48B
-0.68%+6.83%-1.08%+55.36% 49.62B
+1.79%+0.10%-0.55%-8.36% 35.17B
Average +0.48%+0.24%-10.59%+23.26% 79B
Weighted average by Cap. +1.03%-0.38%-9.08%+24.73%

Financials

2024 2025
Net sales 7.57B 8.9B 1.13B 1.03B 951M 858M 1.62B 107B 1.67B 11.43B 4.53B 57.16B 4.26B 4.17B 181B 7.19B 8.45B 1.08B 976M 903M 814M 1.53B 102B 1.59B 10.84B 4.3B 54.23B 4.04B 3.96B 172B
Net income 407M 478M 60.92M 55.21M 51.06M 46.07M 86.82M 5.74B 89.88M 613M 243M 3.07B 229M 224M 9.74B 327M 385M 49.05M 44.45M 41.11M 37.1M 69.91M 4.63B 72.37M 494M 196M 2.47B 184M 180M 7.84B
Net Debt -109M -128M -16.32M -14.79M -13.68M -12.34M -23.26M -1.54B -24.08M -164M -65.15M -822M -61.24M -59.94M -2.61B 119M 140M 17.8M 16.13M 14.92M 13.46M 25.37M 1.68B 26.27M 179M 71.08M 897M 66.81M 65.39M 2.85B
Projected Income Statement - Annual - China Isotope & Radiation Corporation
Logo China Isotope & Radiation Corporation
China Isotope & Radiation Corp is a China-based company mainly engaged in the research, development, manufacturing and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products. The Company operates five business segments. Pharmaceuticals segment is engaged in providing imaging diagnostic and therapeutic radiopharmaceuticals, urea breath test (UBT) kits and analyzers and in vitro diagnostic reagents and kits. Radioactive Source Products segment is engaged in providing various medical and industrial radioactive sources products as well as provision of related technical services. Irradiation segment is engaged in providing sterilization services. Radiation Therapy Equipment and Related Services segment is engaged in manufacturing Radiation therapy equipment. Other Businesses segment is engaged in providing trade services in relation to imported radioactive source, medical nuclides, imported radiopharmaceuticals, and other products.
Employees
3,655
Date Price Change Volume
26-11-13 HK$11.33 -4.79% 152,200
26-11-12 HK$11.90 +1.28% 8,200
26-11-11 HK$11.75 +1.82% 41,400
26-11-10 HK$11.54 +0.44% 12,200
26-11-09 HK$11.49 -1.96% 23,400

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - China Isotope & Radiation Corporation
  1. Stock Market
  2. Stocks
  3. 1763 Stock